Sanofi S.A (SAN) is a multinational pharmaceutical corporation founded in 1973 and headquartered in Paris, France. The French healthcare company engages in the research, development, manufacture, and marketing of pharmaceutical products and solutions internationally. The company covers major health-caring sectors such as diabetes, oncology, thrombosis, and vaccines. Sanofi S.A (SAN) ranked 10th in the top healthcare and pharmaceutical research companies. Sanofi is the 1st vaccine producer in the world. Following Sanofi’s (SAN) collaboration with GSK, the companies have recently announced the start of phase 3 clinical trial for their COVID-19 vaccine, which is distributed by Moderna. The company’s market cap is $110.67B (USD) and is traded on the Euronext, the National Association of Securities Dealers Automated Quotations (NASDAQ), and the CAC 40 index which represents the top 40 corporations on the French Stock Exchange (CAC). Sanofi S.A (SAN) share price appears to be struggling for recovery after a share price plunge occurred in March 2021, when its share price dropped from €94.29 (EUR) July 2020 to €75.35 (EUR) in October of the same year. Investors and speculators are looking forward to the Q2 results by the end of July 2021, given also Sanofi’s candidacy for COVID-19 vaccines.
Sanofi SA (SAN.xpar)
Stay updated with Sanofi SA (SAN.xpar) share price insights and trends. Enhance your trading strategy with FP Markets Mexico.